Chrestos supports you in planning and analysing your clinical studies. We combine sound statistic expertise with up-to-date software experience. We focus on pharmacokinetic and pharmacodynamic tests (phase I), reviewing the therapy concept in Proof-of-Concept studies (phase IIa) as well as in observational studies and non-interventional studies (phase IV). We also cooperate with you when it comes to a successful market approval on the basis of pivotal studies (phase III).
